EVENTIDE ASSET MANAGEMENT, LLC
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1442891
Boston, MA
Position in BBOT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,843,569
-$8,707,603 QoQ
Shares Held
541,181
-50.0% QoQ
Ownership
0.675%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBOT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,248,389 | $146,148,900 | |
| 2 | ARGX |
Argenx SE
|
125,668 | $116,591,000 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
2,111,410 | $116,127,550 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
1,380,219 | $80,232,130 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
316,820 | $77,548,031 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,380,261 | $77,391,234 | |
| 7 | INSM |
INSMED Inc
|
583,665 | $62,230,362 | |
| 8 | BLTE |
Belite Bio, Inc
|
390,829 | $60,181,803 |
All Filings in BBOT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,843,569 | 541,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,551,172 | 1,082,362 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,533,751 | 1,082,362 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||